_id
69105641ccc777a4e85d5615
Ticker
CTABF
Name
Canntab Therapeutics Limited
Exchange
PINK
Address
223 Riviera Drive, Markham, ON, Canada, L3R 5J6
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://canntab.ca
Description
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2025-11-29T11:56:39.899Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
3890
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-02-28
Revenue
-22156
Cost Of Revenue
-17246
Gross Profit
-4910
Operating Expenses
340890
Operating Income
-345800
Interest Expense
161520
Pretax Income
-412628
Net Income
-412628
Eps
-0.010604906675058179
Dividends Per Share
-
Shares Outstanding
38909159
Income Tax Expense
161520
EBITDA
-159599
Operating Margin
1560.7510380935187
Total Other Income Expense Net
-66828
Cash
16814
Short Term Investments
-
Receivables
2531
Inventories
287154
Total Current Assets
336010
Property Plant Equipment
341699
Total Assets
953543
Payables
203582
Short Term Debt
1896060
Long Term Debt
-
Total Liabilities
3113244
Equity
-2159701
Depreciation
91509
Change In Working Capital
57049
Cash From Operations
-37688
Capital Expenditures
2781
Cash From Investing
-2781
Cash From Financing
1967
Net Change In Cash
-38502
PE
-
PB
-0.0018015993417607346
ROE
19.105792885218833
ROA
-43.27314027788993
FCF
-40469
Fcf Percent
1.826548113377866
Piotroski FScore
1
Health Score
48
Deep Value Investing Score
3.5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
8.8
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
3.5
Quality Investing Score
5
Value Investing Score
2
Quarters > 0 > quarter
2023-02-28
Quarters > 0 > income Statement > revenue
-22156
Quarters > 0 > income Statement > cost Of Revenue
-17246
Quarters > 0 > income Statement > gross Profit
-4910
Quarters > 0 > income Statement > operating Expenses
340890
Quarters > 0 > income Statement > operating Income
-345800
Quarters > 0 > income Statement > interest Expense
161520
Quarters > 0 > income Statement > pretax Income
-412628
Quarters > 0 > income Statement > net Income
-412628
Quarters > 0 > income Statement > eps
-0.010604906675058179
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
38909159
Quarters > 0 > income Statement > income Tax Expense
161520
Quarters > 0 > income Statement > EBITDA
-159599
Quarters > 0 > income Statement > operating Margin
1560.7510380935187
Quarters > 0 > income Statement > total Other Income Expense Net
-66828
Quarters > 0 > balance Sheet > cash
16814
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2531
Quarters > 0 > balance Sheet > inventories
287154
Quarters > 0 > balance Sheet > total Current Assets
336010
Quarters > 0 > balance Sheet > property Plant Equipment
341699
Quarters > 0 > balance Sheet > total Assets
953543
Quarters > 0 > balance Sheet > payables
203582
Quarters > 0 > balance Sheet > short Term Debt
1896060
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3113244
Quarters > 0 > balance Sheet > equity
-2159701
Quarters > 0 > cash Flow > net Income
-412627
Quarters > 0 > cash Flow > depreciation
91509
Quarters > 0 > cash Flow > change In Working Capital
57049
Quarters > 0 > cash Flow > cash From Operations
-37688
Quarters > 0 > cash Flow > capital Expenditures
2781
Quarters > 0 > cash Flow > cash From Investing
-2781
Quarters > 0 > cash Flow > cash From Financing
1967
Quarters > 0 > cash Flow > net Change In Cash
-38502
Quarters > 0 > ratios > PE
-0.010604906675058179
Quarters > 0 > ratios > PB
-0.0018015993417607346
Quarters > 0 > ratios > ROE
19.105792885218833
Quarters > 0 > ratios > ROA
-43.27314027788993
Quarters > 0 > ratios > FCF
-40469
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
1.826548113377866
Quarters > 0 > health Score
48
Quarters > 1 > quarter
2022-11-30
Quarters > 1 > income Statement > revenue
17588
Quarters > 1 > income Statement > cost Of Revenue
17167
Quarters > 1 > income Statement > gross Profit
421
Quarters > 1 > income Statement > operating Expenses
499386
Quarters > 1 > income Statement > operating Income
-738971
Quarters > 1 > income Statement > interest Expense
240006
Quarters > 1 > income Statement > pretax Income
-1030774
Quarters > 1 > income Statement > net Income
-1030774
Quarters > 1 > income Statement > eps
-0.02649180877952155
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
38909159
Quarters > 1 > income Statement > income Tax Expense
240006
Quarters > 1 > income Statement > EBITDA
-619047
Quarters > 1 > income Statement > operating Margin
-4201.5635660677735
Quarters > 1 > income Statement > total Other Income Expense Net
-291803
Quarters > 1 > balance Sheet > cash
55316
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
19940
Quarters > 1 > balance Sheet > inventories
481060
Quarters > 1 > balance Sheet > total Current Assets
584286
Quarters > 1 > balance Sheet > property Plant Equipment
766262
Quarters > 1 > balance Sheet > total Assets
1641039
Quarters > 1 > balance Sheet > payables
188464
Quarters > 1 > balance Sheet > short Term Debt
1691387
Quarters > 1 > balance Sheet > long Term Debt
193423
Quarters > 1 > balance Sheet > total Liabilities
3388113
Quarters > 1 > balance Sheet > equity
-1747074
Quarters > 1 > cash Flow > net Income
-1030776
Quarters > 1 > cash Flow > depreciation
171721
Quarters > 1 > cash Flow > change In Working Capital
259045
Quarters > 1 > cash Flow > cash From Operations
-57321
Quarters > 1 > cash Flow > capital Expenditures
12394
Quarters > 1 > cash Flow > cash From Investing
-12394
Quarters > 1 > cash Flow > cash From Financing
-20138
Quarters > 1 > cash Flow > net Change In Cash
-89853
Quarters > 1 > ratios > PE
-0.02649180877952155
Quarters > 1 > ratios > PB
-0.002227104232562559
Quarters > 1 > ratios > ROE
59.00001946111041
Quarters > 1 > ratios > ROA
-62.812279293788876
Quarters > 1 > ratios > FCF
-69715
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-3.9637821241755744
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2022-08-31
Quarters > 2 > income Statement > revenue
38505
Quarters > 2 > income Statement > cost Of Revenue
12019
Quarters > 2 > income Statement > gross Profit
26486
Quarters > 2 > income Statement > operating Expenses
573857
Quarters > 2 > income Statement > operating Income
-761358
Quarters > 2 > income Statement > interest Expense
213987
Quarters > 2 > income Statement > pretax Income
-467805
Quarters > 2 > income Statement > net Income
-467805
Quarters > 2 > income Statement > eps
-0.012023004660676424
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
38909159
Quarters > 2 > income Statement > income Tax Expense
213987
Quarters > 2 > income Statement > EBITDA
-114814
Quarters > 2 > income Statement > operating Margin
-1977.2964550058432
Quarters > 2 > income Statement > total Other Income Expense Net
293553
Quarters > 2 > balance Sheet > cash
145169
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
43746
Quarters > 2 > balance Sheet > inventories
572716
Quarters > 2 > balance Sheet > total Current Assets
1030523
Quarters > 2 > balance Sheet > property Plant Equipment
924966
Quarters > 2 > balance Sheet > total Assets
2246602
Quarters > 2 > balance Sheet > payables
126023
Quarters > 2 > balance Sheet > short Term Debt
1595991
Quarters > 2 > balance Sheet > long Term Debt
151808
Quarters > 2 > balance Sheet > total Liabilities
2979224
Quarters > 2 > balance Sheet > equity
-732622
Quarters > 2 > cash Flow > net Income
-467805
Quarters > 2 > cash Flow > depreciation
139004
Quarters > 2 > cash Flow > change In Working Capital
-156993
Quarters > 2 > cash Flow > cash From Operations
-527039
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-12394
Quarters > 2 > cash Flow > cash From Financing
-18903
Quarters > 2 > cash Flow > net Change In Cash
-545942
Quarters > 2 > ratios > PE
-0.012023004660676424
Quarters > 2 > ratios > PB
-0.005310946026736844
Quarters > 2 > ratios > ROE
63.853528832058004
Quarters > 2 > ratios > ROA
-20.822780358959886
Quarters > 2 > ratios > FCF
-527039
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-13.687547071808856
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2022-05-31
Quarters > 3 > income Statement > revenue
39540
Quarters > 3 > income Statement > cost Of Revenue
93877
Quarters > 3 > income Statement > gross Profit
-54337
Quarters > 3 > income Statement > operating Expenses
896408
Quarters > 3 > income Statement > operating Income
-1161518
Quarters > 3 > income Statement > interest Expense
213203
Quarters > 3 > income Statement > pretax Income
-1444293
Quarters > 3 > income Statement > net Income
-1444293
Quarters > 3 > income Statement > eps
-0.0371196149472159
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
38909159
Quarters > 3 > income Statement > income Tax Expense
210773
Quarters > 3 > income Statement > EBITDA
-1044948
Quarters > 3 > income Statement > operating Margin
-2937.577137076378
Quarters > 3 > income Statement > total Other Income Expense Net
-282775
Quarters > 3 > balance Sheet > cash
691111
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
209720
Quarters > 3 > balance Sheet > inventories
489256
Quarters > 3 > balance Sheet > total Current Assets
1464614
Quarters > 3 > balance Sheet > property Plant Equipment
1083672
Quarters > 3 > balance Sheet > total Assets
2852104
Quarters > 3 > balance Sheet > payables
160917
Quarters > 3 > balance Sheet > short Term Debt
1512619
Quarters > 3 > balance Sheet > long Term Debt
126204
Quarters > 3 > balance Sheet > total Liabilities
3163327
Quarters > 3 > balance Sheet > equity
-311223
Quarters > 3 > cash Flow > net Income
-1444293
Quarters > 3 > cash Flow > depreciation
188572
Quarters > 3 > cash Flow > change In Working Capital
-45645
Quarters > 3 > cash Flow > cash From Operations
-779188
Quarters > 3 > cash Flow > capital Expenditures
13213
Quarters > 3 > cash Flow > cash From Investing
-13213
Quarters > 3 > cash Flow > cash From Financing
-17703
Quarters > 3 > cash Flow > net Change In Cash
-810104
Quarters > 3 > ratios > PE
-0.0371196149472159
Quarters > 3 > ratios > PB
-0.012502019130976826
Quarters > 3 > ratios > ROE
464.07013620458645
Quarters > 3 > ratios > ROA
-50.63956293318898
Quarters > 3 > ratios > FCF
-792401
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-20.040490642387457
Quarters > 3 > health Score
31
Valuation > metrics > PE
-0.010604906675058179
Valuation > metrics > PB
-0.0018015993417607346
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
19.105792885218833
Profitability > metrics > ROA
-122.80229755066814
Profitability > metrics > Net Margin
18.62375880122766
Profitability > final Score
68
Profitability > verdict
Adequate
Risk > metrics > Interest Coverage
-2.140911342248638
Risk > final Score
21
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.16003204355790177
Liquidity > metrics > Quick Ratio
0.023268728668982618
Liquidity > final Score
11
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
18
Prev Risks > 1
16
Prev Risks > 2
8
Prev Liquidities > 0
13
Prev Liquidities > 1
23
Prev Liquidities > 2
39
Updated At
2026-01-20T21:40:08.532Z
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-02-28)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Canntab Therapeutics Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2023-02-28)
(Last Updated 2023-02-28)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-02-28)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-02-28)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.